These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 8453945
1. Neuroprotective effect of felbamate after kainic acid-induced status epilepticus. Chronopoulos A, Stafstrom C, Thurber S, Hyde P, Mikati M, Holmes GL. Epilepsia; 1993; 34(2):359-66. PubMed ID: 8453945 [Abstract] [Full Text] [Related]
2. Felbamate in experimental model of status epilepticus. Mazarati AM, Baldwin RA, Sofia RD, Wasterain CG. Epilepsia; 2000 Feb; 41(2):123-7. PubMed ID: 10691107 [Abstract] [Full Text] [Related]
3. Anticonvulsant activity of felbamate in amygdala kindling model of temporal lobe epilepsy in rats. Wlaź P, Löscher W. Epilepsia; 1997 Nov; 38(11):1167-72. PubMed ID: 9579916 [Abstract] [Full Text] [Related]
4. Effects of felbamate and other anticonvulsant drugs in two models of status epilepticus in the rat. Sofia RD, Gordon R, Gels M, Diamantis W. Res Commun Chem Pathol Pharmacol; 1993 Mar; 79(3):335-41. PubMed ID: 8480078 [Abstract] [Full Text] [Related]
5. Isobolographic and subthreshold analysis of interactions among felbamate and four conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice. Borowicz KK, Luszczki JJ, Czuczwar SJ. Epilepsia; 2004 Oct; 45(10):1176-83. PubMed ID: 15461671 [Abstract] [Full Text] [Related]
6. Basic fibroblast growth factor is highly neuroprotective against seizure-induced long-term behavioural deficits. Liu Z, Holmes GL. Neuroscience; 1997 Feb; 76(4):1129-38. PubMed ID: 9027873 [Abstract] [Full Text] [Related]
7. Effects of magnesium sulfate in kainic acid-induced status epilepticus. Mikati MA, Injibar H, Kurdi RM, El Hokayem J, Abou Rialy S, Lteif L, Abdul Jawad M, Francis E, Geha G, Farhat F. J Med Liban; 2006 Feb; 54(4):200-4. PubMed ID: 17330372 [Abstract] [Full Text] [Related]
8. Levetiracetam and felbamate interact both pharmacodynamically and pharmacokinetically: an isobolographic analysis in the mouse maximal electroshock model. Luszczki JJ, Andres-Mach MM, Ratnaraj N, Patsalos PN, Czuczwar SJ. Epilepsia; 2007 Apr; 48(4):806-15. PubMed ID: 17284299 [Abstract] [Full Text] [Related]
9. Comparison of valproate and phenobarbital treatment after status epilepticus in rats. Bolanos AR, Sarkisian M, Yang Y, Hori A, Helmers SL, Mikati M, Tandon P, Stafstrom CE, Holmes GL. Neurology; 1998 Jul; 51(1):41-8. PubMed ID: 9674776 [Abstract] [Full Text] [Related]
10. A neuropharmacological evaluation of felbamate as a novel anticonvulsant. White HS, Wolf HH, Swinyard EA, Skeen GA, Sofia RD. Epilepsia; 1992 Jul; 33(3):564-72. PubMed ID: 1592038 [Abstract] [Full Text] [Related]
11. Felbamate pharmacology and use in epilepsy. Burdette DE, Sackellares JC. Clin Neuropharmacol; 1994 Oct; 17(5):389-402. PubMed ID: 9316688 [Abstract] [Full Text] [Related]
12. Interaction of felbamate with several other antiepileptic drugs against seizures induced by maximal electroshock in mice. Gordon R, Gels M, Wichmann J, Diamantis W, Sofia RD. Epilepsia; 1993 Oct; 34(2):367-71. PubMed ID: 8453946 [Abstract] [Full Text] [Related]
17. Effects of felbamate, kynurenic acid derivatives and NMDA antagonists on in vitro kainate-induced epileptiform activity. Domenici MR, Marinelli S, Sagratella S. Life Sci; 1996 May 24; 58(26):PL391-6. PubMed ID: 8691980 [Abstract] [Full Text] [Related]